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Summary
Paget-Schroetter syndrome or effort thrombosis is a rare condition 
with potentially severe consequences, affecting young and otherwise 
healthy athletes. Its classic clinical presentation should be rapidly 
identified to promote early diagnosis and treatment. This prevents 
recurrences and long-term complications such as persistent swell-
ing of the affected arm. In a 1-year period we saw two young male 
athletes with this condition. One was treated conservatively and the 
other surgically, with vastly different outcomes. We therefore present 
their cases as well as a review of relevant literature to emphasise 
treatment of this rare condition.
Case 1
A 23-year-old male professional road cyclist presented 2 days after 
an acute onset of swelling of the right arm. He had been given a 
new bicycle by his sponsor, and had gone for a 4-hour cycle. His 
position on the new bike was slightly different to his previous cy-
cling position, with the handlebars being slightly closer to his body, 
and he noticed swelling and heaviness of his right arm the following 
day. On examination, his right arm was markedly swollen from the 
axilla to the fingers, with the biceps diameter being 30 cm on the 
right compared with 27 cm on the left. He had normal pulses and 
no adverse neurological findings. A duplex Doppler of the arm re-
vealed no thrombus formation, and the veins were reported as hav-
ing normal compressibility. A venogram was then conducted, which 
showed a deep vein thrombosis (DVT) of the right subclavian vein, 
related to the medial third of the clavicle and first rib with early col-
lateral formation. Risk factors for thrombus formation include a ma-
lignant melanoma which had been excised 13 years previously, a 
high haematocrit (49.4%), the cyclist’s posture, and the new cycling 
position adopted on the new bicycle. Blood investigations included 
a thrombotic work-up, which was completely normal. His X-rays of 
chest and cervical spine were both normal. There was no evidence 
of recurrence of the melanoma.
Treatment with anticoagulation was initiated within 2 days of 
his initial presentation. He was offered thrombolysis of the clot, 
but refused this treatment. Thrombolysis is usually performed by 
insertion of a percutaneous catheter, and a haemolytic agent is 
infiltrated directly into the site of the clot. The procedure is usually 
performed at the same time as the venogram, as the same catheter 
may be used for both procedures. 
When his swelling persisted beyond 7 days he requested further 
intervention, and was offered surgical excision of the affected 
vein with first rib resection to decompress the thoracic outlet. His 
surgery was performed 2 weeks after the initial presentation, and 
included the above-mentioned treatment and a saphenous vein 
graft to anastamose the subclavian vein. Unfortunately, several 
intraoperative complications were encountered including a laceration 
of the pleura, haemothorax, on-table severe bradycardia presumed 
to be caused by a pulmonary embolus and requiring resuscitation, 
and severing of the phrenic nerve.
The patient managed to overcome these complications, 
continued anticoagulant therapy for 6 months, and then attempted 
unsuccessfully to return to professional cycling. He was followed up 
a year later, and found to have no residual swelling of the arm.
Case 2
Case 2 was a 25-year-old amateur rugby prop forward. He described 
a tearing sound in his left shoulder, which occurred when he per-
formed a spear tackle (an action that he described as being similar to 
a dead-lift in weight lifting) on another player. He presented 2 weeks 
later in the consulting rooms with marked swelling and heaviness 
of his right arm. The diameters of his arms at biceps level were 47 
cm and 42 cm respectively. The pulses of his right arm felt weak 
due to the swelling of the arm, and he had no neurological deficit 
in the arm. He was markedly tender to palpation and swollen over 
the right coracoid process. The initial Doppler of his subclavian and 
axillary vein showed no abnormality, but when it was repeated by an 
experienced vascular surgeon, it showed a DVT at the junction of the 
subclavian and jugular veins on the right side. Anticoagulant therapy 
and a pressure stocking of the arm were initiated at his first visit. He 
was offered thrombolysis, but he too refused the treatment. He was 
treated with physical therapy for a torn pectoralis minor muscle that 
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was thought to have caused the thrombosis, and postural correction. 
At 3-month follow-up he had no residual swelling of his arm, and was 
scheduled to undergo positional venography to assess the patency 
of the subclavian vein and exclude thoracic outlet compression of the 
vein when he was lost to follow-up. 
He has since been contacted, is completely symptom free, and 
has no recurrent swelling of his arm at all. 
Discussion
DVT is a common condition, but only 2 - 4% of all DVTs involve 
the upper limb.1-6 Primary subclavian vein thrombosis is a relatively 
uncommon condition, affecting 2/100 000 people per year, which 
represents 15 - 24% of all upper limb DVTs,
7,8 but it is the most 
common vascular disorder affecting professional, collegiate or high-
school athletes.5,7,9
It was first described by Sir James Paget in 1858, and later by 
Leold van Schroetter in 1884. The English surgeon, Hughes, gave 
it the eponym Paget-Schroetter syndrome (PSS) when he reviewed 
320 cases from literature in 1949. 
2,3,5-8,10,11 Another synonym for 
the condition in literature is ‘effort thrombosis’, which emphasises the 
causal relationship between certain forms of exercise and thrombosis 
of the subclavian vein.4,6 This relationship was first identified by Von 
Schroetter in 1899.
2,8
PSS occurs primarily in young, otherwise healthy subjects 
(mean age 15 - 30 years) who participate in repetitive upper limb 
activities.3,4,7-10 It occurs twice as frequently in men as in women, 
affecting the right or dominant arm in 80% of cases.
1,2,5,6,8 It has been 
reported in many sports, including golf, American football, weight 
lifting, baseball, wrestling, tennis, martial arts, backpacking, billiards, 
swimming, rowing and cheerleading.1-3,10 Because of the youth and 
otherwise healthy state of those presenting with this condition, it is 
often ignored or misdiagnosed.8 In a series of eight patients with 
the condition, Zell et al. found that five of the eight patients were 
untrained athletes for whom exercise was not the norm.2
The mechanism of thrombosis is through a thoracic outlet 
compression and/or repetitive intimal strain of the axillary or subclavian 
vein by retroversion and hyperabduction of the arm.7,9 Repetitive 
intimal strain can lead to inflammation and traumatic fissures in the 
intima of the vein, resulting ultimately in thrombus formation.2,4,6,10,11 
Compression of the vein in the thoracic outlet through lateral 
abduction of the arm or hypertrophy of subclavian or anterior scalene 
muscles can cause turbulence in the vein, which is exacerbated by 
increased venous flow experienced during exercise.
2,10
 Thrombosis 
occurs most commonly at the level of the subclavian vein where it 
crosses the thoracic outlet and may be compressed.4 Lifting of heavy 
weights can also cause compression of the vein in the thoracic outlet 
by depression of the shoulder, causing compression of the vein 
between the clavicle and first rib.
8,10 
The occurrence of PSS can also be contributed to by a 
hypercoagulable state10 and upper limb thromboses are more 
frequently associated with underlying malignant disorders than those 
in the lower limb.11 Melby et al. stated that the chronic repetitive 
compression and intimal micro-trauma that result in PSS make it 
an acute manifestation of a chronic condition rather than a single 
traumatic event.9 This observation is important in the management 
of the condition, as it is essential to treat the causative pathology to 
prevent recurrence.9
PSS should be distinguished aetiologically from other subclavian 
DVTs, which are caused by primary diseases and other known risk 
factors such as malignant neoplasms, treatment with central venous 
catheters or pacemakers, or cervical ribs.2 These patients develop 
secondary thrombosis, and are older, and have concurrent systemic 
illness.3
The anatomical relations of the subclavian vein in the thoracic 
outlet are: 
•    superior and anterior: the clavicle, subclavius muscle and 
costoclavicular ligament 
•    inferior: first rib 
•    posterior: anterior scalene muscle.
1,3,8 
Other structures which are in close relation to the subclavian 
vein in and around the thoracic outlet include: pectoralis minor and 
supraspinatus muscles, coracocostal ligament, osseous exostoses, 
cervical ribs, fibrous cords.
3,8 Cervical ribs are present in between 
0.5% and 1% of the general population, but cause symptoms in less 
than 10% of these people, most of whom have arterial or neurological 
thoracic outlet syndromes.3
Patients present with symptoms of venous obstruction of the 
arm including a dull aching pain, non-oedematous swelling, a 
feeling of heaviness in the arm, and bluish discolouration of the 
arm.6-8,10 Symptoms range in severity, may be position-dependent, 
and occasionally the patient may be asymptomatic.7,8 Differential 
diagnosis includes: 
•    fracture of the mid-shaft of the humerus
•    soft-tissue injury or infection with compartment syndrome
•    muscular strain or sprain resulting in local tenderness and 
swelling.6
Pulmonary thrombo-embolism is a rare complication of PSS, and 
occurs in between 7% and 20% of cases.
3-5,7
Early and accurate diagnosis is of paramount importance to 
prevent long-term complications and recurrence.2,3 It has been stated 
that with PSS the earlier the diagnosis and treatment, the better the 
outcome.11 Duplex Doppler is the first diagnostic test of choice, as 
it is non-invasive, and is reported as having a high sensitivity and 
specificity for peripheral DVT. 
7
 Melby et al., however, reported a 
relatively low diagnostic sensitivity of 71% of duplex Doppler to 
upper extremity thrombosis,9 and Shebel states that it is only reliable 
for thrombus extending into the axillary vein.8 They stated that this is 
as a result of technical difficulties in visualising the subclavian vein 
below the clavicle, especially in the presence of extensive collateral 
veins, and the inability to compress the vein within the thoracic 
outlet.8,9 They therefore suggested that a negative duplex Doppler 
should not exclude thrombosis, and that contrast venography should 
be the diagnostic test of choice.1,6,8,9 Positional venography with 
the arm in neutral, abducted and externally rotated positions, is 
also of value in not only assessing costoclavicular compression of 
the subclavian vein, but also compression of collateral veins with 
positional changes of the arm.8
There is no consensus on the optimal treatment of PSS, as most 
published data consist of individual case reports and small series.3,5,11 
Hiken and Ameli conducted a literature review to determine the most 
appropriate treatment for PSS, and concluded that since treatments, 
follow-up and conclusions reported were so varied, optimal 
treatment remains controversial.12 Traditional treatment consists 
of anticoagulation and elevation of the limb to facilitate thrombus 
resolution, and prevent further thrombus formation.3,7 There are 
varying reports of the incidence of post-thrombotic syndrome (PTS), 
which is characterised by chronic swelling and heaviness of the 
arm and hand. Incidences of PTS of between 41% and 73% 
3-6,11 
with conservative treatment have been reported, with severity of 
symptoms ranging vastly.  Historically most authors have concluded, 
in the light of these varying data, that non-operative treatment of 
axillary thrombosis provided a predictably good outcome, and that 
surgical intervention was not warranted.3
Despite these conclusions, there was persistent concern over 
residual symptoms following PSS treated with anticoagulation therapy 
alone, which ‘rarely produces symptom-free use of the arm, and 
imposes limitations that appear unacceptable to most patients’. 
9
 This 
led to the advent of catheter-directed thrombolysis, which is currently 
regarded as the initial treatment of choice, 5 as a treatment.3,10 As 
mentioned previously, this involves injection of a thrombolytic agent 
into the site of the thrombus via a percutaneous catheter. The 
procedure is often performed at the time of venography, as the same 
catheter can be used for both procedures. The advantage of early 
thrombolysis is that it restores venous patency, thus minimising the 
damage to the endothelium, and reducing the risk of post-thrombotic 
syndrome. 3,7
Venous patency is accepted as the main factor in preventing 
residual symptoms.3 This has been shown to be achieved through 
thrombolysis alone if the treatment is initiated within 1 week of the 
onset of symptoms.5,6,13  Fibrinolysis alone is unsuccessful in 
nearly 20% of patients even when undertaken within a week of 
onset of symptoms.5 There is a greater incidence of fibrous stricture 
formations at the site of the thrombus if thrombolysis occurs beyond 
1 week. In these cases, further surgical intervention such as vein patch 
angioplasty and decompression of the thoracic outlet is indicated.13
Other methods of overcoming strictures have been tried, including 
balloon angioplasty and the placement of stents. Balloon angioplasty 
is usually unsuccessful due to extrinsic compression of the subclavian 
vein and dense perivenous scar tissue, which results in immediate 
recoil or re-stenosis.5,9 Endoluminal stents are similarly an ineffective 
treatment, as subclavian vein compression frequently results in 
bending or fracture of the stent with subsequent re-thrombosis.5,9
Defining whether or not the patient has a pre-existing anatomical 
anomaly is essential in determining which patients will benefit from 
surgical decompression of the thoracic outlet, as PSS cannot be 
effectively treated without addressing compressive mechanisms 
causing thrombogenesis.5,7 If extrinsic venous compression is 
identified, many surgeons advocate early decompression of the 
thoracic outlet via resection of the first rib or clavicle. Others, however, 
recommend a trial of conservative therapy after thrombolysis.7 
Hicken et al. stated that surgical intervention should be reserved for 
patients in whom there is a specific indication.
12
In a series of 32 cases of PSS treated between January 1997 
and January 2007, Melby et al. showed excellent results to surgical 
intervention.9 They offered surgical treatment to all patients. Their 
treatment included thoracic outlet decompression via complete 
anterior and middle scalenectomy, brachial plexus neurolysis, excision 
of subclavius muscle tendon, and resection of the first rib. They also 
performed external venolysis of the subclavian vein on all patients, 
excising all scar tissue from the axillary vein to the subclavian-
jugular-innominate vein junction. They were able to demonstrate 
normal compressibility of the vein through palpation or intraoperative 
venography in 56% of the patients. These patients had no further 
venous reconstruction. The remaining 44% had residual narrowing of 
the subclavian vein in at least one portion. The affected section of the 
vein was resected, and reconstructed using an autologous saphenous 
vein patch. In 59% of the patients they also created a radiocephalic 
arteriovenous fistula, which assisted in maintaining flow through the 
grafted area.9 The median time to full return to competitive sport in 
their series was 3.5 months from the time of surgery (range 2 - 10 
months), with 50% of the patients resuming sports participation by 3 
months.9 They found that there was no difference in time to return to 
sporting activities after operative intervention in patients with delayed 
diagnosis or recurrent symptoms.9
Conclusion
PSS is a rare condition, but the most common vascular condition 
affecting athletes. It may present with subtle symptoms, but early 
diagnosis is imperative in being able to initiate early treatment. Du-
plex Doppler, although the first diagnostic test of choice, is unable to 
always definitively exclude the condition, and venography is recom-
mended if there is clinical suspicion and a negative Doppler test. 
Anticoagulation is important to prevent thrombus proliferation, but 
is often unsuccessful as a sole treatment for PSS. Thrombolysis is 
often successful in restoring venous patency and preventing long-
term sequelae of post-thrombotic syndrome if performed within 7 
days of the onset of the condition. Surgical intervention may be re-
quired to restore venous patency and compressibility and to relieve 
external compression of the vein in the thoracic outlet. These can 
be assessed through positional venography in the patient who has 
completely symptomatically recovered with conservative treatment. 
Failure to achieve complete recovery with conservative treatment 
alone is an indication for further intervention. Surgical options in-
clude external venolysis, resection of affected segments of vein with 
saphenous vein patching, and thoracic outlet decompression via first 
rib resection or scalene or subclavian muscle resection. 
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